This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI ZAP 70
catalog :
VMA00059
quantity :
100 µl
price :
346 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00059
Description :
MOUSE ANTI ZAP 70
Specificity :
ZAP 70
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB
ApplicationTypes :
Western Blotting
Quantity :
100 µl
QuantityValue :
100
QuantityType :
ul
GOAccessions :
GO:0045059,GO:0050852,GO:0006955,GO:0005524,GO:0007243,GO:0042101,GO:0005829,GO:0004715
GOTerms :
ATP:protein-L-tyrosine O-phosphotransferase (non-specific) activity,ATP:protein-tyrosine O-phosphotransferase activity,Bruton's tyrosine kinase activity,cytoplasmic protein tyrosine kinase activity,focal adhesion kinase activity,janus kinase 1 activity,janus kinase 2 activity,janus kinase 3 activity,non-specific protein-tyrosine kinase activity,p60c-src protein tyrosine kinase activity,protein kinase cascade,T lymphocyte receptor complex,T-cell receptor complex,TCR,T-lymphocyte receptor complex,positive thymic T lymphocyte selection,positive thymic T-cell selection,positive thymic T-lymphocyte selection,T lymphocyte receptor signaling pathway,T lymphocyte receptor signalling pathway,T-cell receptor signaling pathway,T-cell receptor signalling pathway,TCR signaling pathway,T-lymphocyte receptor signaling pathway,T-lymphocyte receptor signalling pathway
UniprotAccessions :
P43403
Gene :
ZAP70
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7535
EntityFormats :
Purified
UNSPSC :
41116161
ProductForm :
Purified IgG - liquid
PriceGBP :
262
PriceEUR :
336
PriceUSD :
346 USD
PriceCHF :
366.24
PriceSEK :
3531
PriceNOK :
3599
PriceDKK :
2507
NotForSaleInCountries :
Korea, South
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments